Coronavirus Latest News

Drug firms poised to make billions of dollars from Covid booster jabs

Sales of BioNTech, Moderna and Pfizer drugs could rival $6bn-a-year market for flu vaccines, say analysts

The drug companies Pfizer, BioNTech and Moderna are poised to make billions of dollars from Covid-19 booster jabs this autumn, with analysts estimating that sales could rival the $6bn-a-ear market for seasonal flu vaccines.

The UK government is expected to announce details of its booster programme in the coming days, based on formal advice from the Joint Committee on Vaccination and Immunisation, but the health secretary, Sajid Javid, has suggested the over-50s could be offered a dose along with their winter flu jabs.

Continue reading…

Read the original article at The Guardian

Related Articles

Back to top button